Single Centre Experience of Chelating Agents in Cystinuria

    April 2022 in “ The Journal of Urology
    Bitar Nadia, Purvor Trevor, Foran Niamh, Wells Hayley, Rottenberg Giles, Game David, Bultitude Matthew, Thomas Kay
    Studysummary This study observed that discontinuation rates due to side effects were similar for penicillamine and tiopronin among cystinuria patients, and switching to the alternative agent was beneficial for half of those experiencing issues.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →